Лист за преговор: Diabetes Fundamentals and Management

📋 Course Outline

1. Diabetes Types
2. Pathophysiology
3. Signs and Symptoms
4. Complications
5. Management Goals
6. Nursing Assessment
7. Patient Education
8. Insulin Therapy
9. Oral Hypoglycemics
10. Monitoring and Follow-up

📖 1. Diabetes Types

🔑 Key Concepts & Definitions

• Type 1 Diabetes: An autoimmune disorder where the body's immune system destroys pancreatic beta cells, resulting in little or no insulin production.
• Type 2 Diabetes: A metabolic condition characterized by insulin resistance and relative insulin deficiency, often associated with obesity and sedentary lifestyle.
• Gestational Diabetes: Elevated blood glucose levels that develop during pregnancy, usually resolving postpartum but increasing future diabetes risk.
• Insulin Resistance: A state where body's cells do not respond effectively to insulin, leading to elevated blood glucose levels.
• Autoimmune Destruction: The immune system's attack on the body's own tissues—in Type 1 diabetes, specifically pancreatic beta cells.
• Hyperglycemia: Elevated blood glucose levels resulting from insufficient insulin action or secretion.

📝 Essential Points

• Types Differ in Pathophysiology: Type 1 involves autoimmune destruction; Type 2 involves insulin resistance and relative insulin deficiency; Gestational develops during pregnancy due to hormonal changes.
• Onset and Management: Type 1 typically begins in childhood/adolescence and requires insulin; Type 2 is more common in adults, managed with lifestyle, oral meds, and sometimes insulin; Gestational diabetes requires monitoring and management during pregnancy.
• Risk Factors: Genetic predisposition, obesity, sedentary lifestyle, family history, and pregnancy-related factors.
• Screening Recommendations: Begin screening for Type 2 in adults at age 45 or earlier with risk factors; gestational diabetes screening occurs during pregnancy.

💡 Key Takeaway

Understanding the distinct types of diabetes—autoimmune, resistance-based, and pregnancy-related—is essential for targeted management and prevention of complications, with each type requiring specific treatment approaches.

📖 2. Pathophysiology

🔑 Key Concepts & Definitions

• Autoimmune destruction: An immune response where the body's immune system attacks its own tissues—in Type 1 diabetes, pancreatic beta cells are targeted, leading to insulin deficiency.

• Insulin resistance: A condition where body cells (muscle, fat, liver) respond inadequately to insulin, resulting in decreased glucose uptake and elevated blood glucose levels, primarily seen in Type 2 diabetes.

• Hyperglycemia: Elevated blood glucose levels due to insufficient insulin action, characteristic of all types of diabetes.

• Glucose homeostasis: The balance of glucose production and utilization in the body, regulated by insulin and counter-regulatory hormones; disruption leads to diabetes.

• Ketogenesis: The process of ketone body formation in the liver, which occurs during insulin deficiency, leading to diabetic ketoacidosis in Type 1 diabetes.

• Compensatory mechanisms: Physiological responses such as increased insulin secretion or hepatic glucose production attempting to maintain normoglycemia, which can become overwhelmed in diabetes.

📝 Essential Points

• Type 1 diabetes results from autoimmune destruction of pancreatic beta cells, causing absolute insulin deficiency; often presents with rapid onset and ketoacidosis.

• Type 2 diabetes involves insulin resistance and relative insulin deficiency, developing gradually, often associated with obesity and metabolic syndrome.

• Insulin resistance impairs glucose uptake in peripheral tissues, leading to hyperglycemia; compensatory hyperinsulinemia may initially mask high blood glucose.

• Chronic hyperglycemia damages microvascular (retinopathy, nephropathy, neuropathy) and macrovascular (cardiovascular disease) tissues through mechanisms like glycation end-products and oxidative stress.

• The interplay between insulin deficiency and resistance disrupts glucose, lipid, and protein metabolism, contributing to the development of diabetic complications.

💡 Key Takeaway

Diabetes pathophysiology centers on the disruption of insulin production and action, leading to persistent hyperglycemia that damages tissues over time; understanding these mechanisms is essential for effective management and prevention of complications.

📖 3. Signs and Symptoms

🔑 Key Concepts & Definitions

• Polyuria: Excessive urination resulting from osmotic diuresis caused by high blood glucose levels.
• Polydipsia: Increased thirst due to dehydration from fluid loss through urination.
• Polyphagia: Increased hunger caused by cells' inability to utilize glucose effectively, leading to energy deficiency.
• Fatigue: Feelings of tiredness and weakness due to inadequate glucose uptake by cells.
• Blurred Vision: Visual disturbances caused by fluid shifts in the lens of the eye, affecting refraction.
• Ketonuria: Presence of ketones in urine, indicating fat breakdown and ketosis, common in uncontrolled Type 1 diabetes.

📝 Essential Points

• Classic symptoms (polyuria, polydipsia, polyphagia) are key indicators of hyperglycemia.
• Symptoms may develop gradually in Type 2 diabetes, sometimes remaining unnoticed.
• Severe hyperglycemia can lead to diabetic ketoacidosis (DKA) or hyperosmolar hyperglycemic state (HHS), with more pronounced symptoms like nausea, vomiting, abdominal pain, and altered mental status.
• Diagnostic thresholds: Fasting glucose ≥126 mg/dL, A1C ≥6.5%, or 2-hour OGTT ≥200 mg/dL.
• Recognizing early signs allows for prompt intervention to prevent complications.

💡 Key Takeaway

Recognizing the hallmark signs of hyperglycemia—polyuria, polydipsia, and polyphagia—is essential for early diagnosis and management of diabetes, preventing progression to severe complications.

📖 4. Complications

🔑 Key Concepts & Definitions

• Diabetic Ketoacidosis (DKA): An acute, life-threatening complication mainly in Type 1 diabetes, characterized by hyperglycemia, metabolic acidosis, and ketonuria due to insulin deficiency and increased lipolysis.
• Hyperglycemic Hyperosmolar State (HHS): A severe hyperglycemic crisis typically in Type 2 diabetes, marked by extreme hyperglycemia, dehydration, and increased serum osmolality without significant ketosis.
• Microvascular Complications: Damage to small blood vessels caused by chronic hyperglycemia, leading to retinopathy, nephropathy, and neuropathy.
• Macrovascular Complications: Large vessel damage resulting in cardiovascular diseases such as coronary artery disease, cerebrovascular disease, and peripheral arterial disease.
• Neuropathy: Nerve damage due to microvascular injury, presenting as peripheral numbness, tingling, or autonomic dysfunction.
• Retinopathy: Damage to retinal blood vessels, leading to vision impairment or blindness.

📝 Essential Points

• Acute complications like DKA and HHS require immediate medical intervention to correct hyperglycemia, dehydration, and electrolyte imbalances.
• Chronic complications develop over years of poorly controlled blood glucose and include retinopathy (vision loss), nephropathy (kidney failure), and neuropathy (sensory and autonomic dysfunction).
• Microvascular damage is closely linked to the duration and control of blood glucose levels; early detection via regular screening (e.g., eye exams, urine microalbumin) is critical.
• Macrovascular disease increases the risk of heart attack, stroke, and peripheral arterial disease; management includes controlling blood pressure, lipids, and lifestyle factors.
• Prevention of complications hinges on maintaining blood glucose within target ranges, blood pressure control, lipid management, and patient education on foot and eye care.
• Signs of DKA include fruity-smelling breath, rapid breathing, abdominal pain, and confusion; HHS presents with profound dehydration and neurological deficits.

💡 Key Takeaway

Chronic hyperglycemia leads to microvascular and macrovascular complications, which can be prevented or delayed through strict blood glucose control, regular screenings, and comprehensive management of cardiovascular risk factors. Immediate treatment of acute complications like DKA and HHS is vital to prevent mortality.

📖 5. Management Goals

🔑 Key Concepts & Definitions

• Glycemic Control: The maintenance of blood glucose levels within target ranges to prevent acute and chronic complications of diabetes.
• Blood Glucose Targets: Specific blood sugar levels set for individuals with diabetes, typically fasting 80-130 mg/dL and postprandial <180 mg/dL.
• A1C (Glycated Hemoglobin): A blood test reflecting average blood glucose levels over the past 2-3 months; goal is usually <7% for most adults.
• Prevention of Complications: Strategies aimed at avoiding microvascular (retinopathy, nephropathy, neuropathy) and macrovascular (cardiovascular disease) issues.
• Patient-Centered Goals: Personalized management objectives considering age, comorbidities, and patient preferences to optimize health outcomes.
• Lifestyle Modification: Non-pharmacologic interventions including diet, exercise, weight management, and smoking cessation to support glycemic control.

📝 Essential Points

• The primary goal of diabetes management is to maintain blood glucose levels within individualized target ranges to prevent both hyperglycemia and hypoglycemia.
• Achieving and maintaining an A1C below 7% reduces the risk of microvascular and macrovascular complications.
• Blood pressure and lipid management are integral to comprehensive diabetes care, reducing cardiovascular risk.
• Patient education on self-monitoring, medication adherence, diet, and exercise is essential for effective management.
• Management plans should be tailored to patient-specific factors such as age, comorbidities, and risk of hypoglycemia.
• Regular follow-up and monitoring (A1C testing every 3-6 months, foot and eye exams) are critical components of ongoing care.

💡 Key Takeaway

Effective management of diabetes aims to keep blood glucose levels within personalized targets through a combination of medication, lifestyle changes, and regular monitoring to prevent complications and promote overall health.

📖 6. Nursing Assessment

🔑 Key Concepts & Definitions

• Nursing Assessment: A systematic process of collecting, verifying, and analyzing patient data to identify health status, needs, and risks related to diabetes management.

• Subjective Data: Information provided directly by the patient, such as symptoms (e.g., thirst, fatigue), lifestyle habits, and medical history.

• Objective Data: Observable and measurable data gathered through physical examination, vital signs, laboratory results (e.g., blood glucose levels, A1C), and foot or eye assessments.

• Health History: Comprehensive record including family history of diabetes, previous glucose readings, medication adherence, and lifestyle factors influencing diabetes control.

• Physical Examination: Evaluation focusing on BMI, blood pressure, skin integrity, foot health, and signs of complications like neuropathy or retinopathy.

• Risk Identification: Recognizing factors that predispose patients to poor glycemic control or complications, such as obesity, sedentary lifestyle, or inadequate knowledge.

📝 Essential Points

• Conduct thorough history-taking to understand symptoms, medication use, and lifestyle factors affecting blood glucose.
• Perform physical assessments including vital signs, BMI, foot, and eye exams to detect early signs of complications.
• Use laboratory data (blood glucose, A1C, lipid profile, urine microalbumin) to evaluate current control and risk.
• Identify nursing diagnoses such as "Risk for Unstable Blood Glucose" or "Ineffective Health Management."
• Continuous assessment guides individualized care plans, patient education, and timely interventions.

💡 Key Takeaway

Effective nursing assessment integrates subjective and objective data to identify patient needs, enabling targeted interventions to optimize diabetes management and prevent complications.

📖 7. Patient Education

🔑 Key Concepts & Definitions

• Patient Education: The process of providing individuals with information and skills to manage their health condition effectively, promoting self-care and informed decision-making.
• Self-Monitoring of Blood Glucose (SMBG): Patients regularly check their blood glucose levels using a glucometer to manage and adjust their treatment plan.
• Health Promotion: Strategies aimed at improving overall health and preventing complications through lifestyle modifications, education, and early detection.
• Adherence: The extent to which a patient follows prescribed treatment regimens, including medication, diet, and lifestyle changes.
• Informed Consent: Ensuring patients understand their condition, treatment options, risks, and benefits before agreeing to interventions or procedures.

📝 Essential Points

• Patient education is vital for effective diabetes management, reducing complications, and enhancing quality of life.
• Education should be individualized, considering the patient’s literacy, cultural background, and readiness to learn.
• Key topics include medication administration (insulin, oral agents), dietary management, physical activity, foot care, and recognizing symptoms of hypo/hyperglycemia.
• Use teach-back methods to confirm understanding and reinforce learning.
• Encourage regular self-monitoring and proper documentation of blood glucose readings.
• Address barriers to adherence, such as financial constraints, lack of knowledge, or psychological factors.
• Ongoing education and support are necessary as patients’ needs evolve over time.

💡 Key Takeaway

Patient education empowers individuals with diabetes to manage their condition confidently, prevent complications, and improve their overall health outcomes through tailored, comprehensive teaching and support.

📖 8. Insulin Therapy

🔑 Key Concepts & Definitions

• Insulin: A hormone produced by the pancreatic beta cells that facilitates the uptake of glucose into cells, lowering blood glucose levels.
• Basal Insulin: Long-acting insulin administered to provide a steady level of insulin throughout the day and night.
• Bolus Insulin: Rapid- or short-acting insulin given before meals to manage postprandial blood glucose spikes.
• Insulin Resistance: A condition where body tissues respond inadequately to insulin, requiring higher doses for glucose regulation.
• Insulin Pump: A device that delivers continuous subcutaneous insulin infusion, mimicking natural insulin release.
• Hypoglycemia: A potentially dangerous condition caused by excess insulin, leading to abnormally low blood glucose levels.

📝 Essential Points

• Types of Insulin: Rapid-acting (e.g., Lispro), short-acting (Regular), intermediate-acting (NPH), long-acting (Glargine, Detemir). Each has specific onset, peak, and duration.
• Administration: Subcutaneous injection is most common; methods include syringes, pens, or insulin pumps.
• Timing: Insulin regimens are tailored based on blood glucose patterns, lifestyle, and type of diabetes.
• Storage: Unopened insulin should be refrigerated; opened insulin can be kept at room temperature for a specified period.
• Monitoring: Regular blood glucose testing is essential to adjust insulin doses and prevent hypo/hyperglycemia.
• Patient Education: Proper injection technique, site rotation, recognizing hypoglycemia symptoms, and managing insulin doses are critical.

💡 Key Takeaway

Insulin therapy is a cornerstone in diabetes management, requiring precise administration, patient education, and ongoing monitoring to achieve optimal glycemic control and prevent complications.

📖 9. Oral Hypoglycemics

🔑 Key Concepts & Definitions

• Oral Hypoglycemic Agents (OHAs): Medications taken by mouth to lower blood glucose levels in people with type 2 diabetes, primarily by improving insulin sensitivity, secretion, or decreasing glucose production.

• Biguanides (e.g., Metformin): A class of oral hypoglycemics that reduce hepatic glucose production and enhance insulin sensitivity, making it the first-line therapy for type 2 diabetes.

• Sulfonylureas (e.g., Glipizide, Glyburide): Drugs that stimulate pancreatic beta cells to increase insulin secretion, thereby lowering blood glucose.

• DPP-4 Inhibitors (e.g., Sitagliptin): Medications that inhibit the enzyme dipeptidyl peptidase-4, prolonging incretin activity, which enhances insulin release and decreases glucagon secretion.

• Alpha-Glucosidase Inhibitors (e.g., Acarbose): Agents that delay carbohydrate absorption in the intestines, reducing postprandial blood glucose spikes.

• SGLT2 Inhibitors (e.g., Canagliflozin): Drugs that block sodium-glucose co-transporter 2 in the kidneys, promoting urinary glucose excretion and lowering blood glucose levels.

📝 Essential Points

• Mechanisms of Action: Different classes target various pathways—insulin secretion, insulin sensitivity, glucose absorption, or renal glucose reabsorption—to control hyperglycemia.

• Combination Therapy: Often used to achieve better glycemic control; understanding drug interactions and side effects is vital.

• Side Effects & Precautions:

  • Metformin: Risk of lactic acidosis, contraindicated in renal impairment.
  • Sulfonylureas: Hypoglycemia and weight gain.
  • DPP-4 inhibitors: Generally well tolerated; monitor for pancreatitis.
  • SGLT2 inhibitors: Increased risk of urinary tract infections, dehydration.

• Patient Education: Emphasize adherence, recognize side effects, and importance of lifestyle modifications alongside medication.

• Monitoring: Regular blood glucose and A1C testing to assess effectiveness; monitor renal function especially with Metformin and SGLT2 inhibitors.

💡 Key Takeaway

Oral hypoglycemic agents are essential in managing type 2 diabetes by targeting different physiological pathways; understanding their mechanisms, side effects, and proper patient education is crucial for effective and safe therapy.

📖 10. Monitoring and Follow-up

🔑 Key Concepts & Definitions

• Blood Glucose Monitoring: The regular measurement of blood glucose levels using devices like glucometers to assess glycemic control.
• A1C Test: A blood test that measures the average blood glucose over the past 2-3 months, reflecting long-term glycemic control.
• Self-Monitoring of Blood Glucose (SMBG): The process by which patients check their blood sugar levels at home to manage daily diabetes care.
• Follow-up Care: Scheduled medical evaluations to monitor disease progression, treatment efficacy, and prevent complications.
• Microvascular Complications: Diabetes-related damage to small blood vessels, leading to retinopathy, nephropathy, and neuropathy.
• Macrovascular Complications: Large vessel damage associated with increased risk of cardiovascular diseases like heart attack and stroke.

📝 Essential Points

• Regular monitoring of blood glucose and A1C levels is vital for assessing control and adjusting treatment.
• A1C testing is recommended every 3-6 months; goal typically <7%, but individualized based on patient factors.
• Follow-up includes screening for complications: foot exams, eye exams, kidney function tests.
• Effective follow-up reduces the risk of acute and chronic complications by early detection and intervention.
• Patient education on SMBG technique and interpretation enhances self-management and adherence.
• Consistent monitoring helps identify patterns, hypoglycemia, or hyperglycemia, guiding timely treatment adjustments.

💡 Key Takeaway

Regular monitoring and structured follow-up are essential components of diabetes management, enabling early detection of complications and optimizing glycemic control to improve patient outcomes.

📊 Synthesis Tables

Aspect	Type 1 Diabetes	Type 2 Diabetes	Gestational Diabetes
Pathophysiology	Autoimmune destruction of beta cells	Insulin resistance + relative deficiency	Hormonal changes during pregnancy cause insulin resistance
Onset	Childhood/Adolescence	Adults, often insidious	During pregnancy
Insulin Dependence	Usually requires insulin therapy	May require insulin, oral meds	Managed during pregnancy, may need insulin
Risk Factors	Autoimmune, genetics, young age	Obesity, sedentary lifestyle, genetics	Pregnancy-related factors, obesity
Key Features	Rapid onset, DKA, polyuria, weight loss	Gradual onset, obesity, metabolic syndrome	Elevated blood glucose during pregnancy
Management	Insulin therapy, carbohydrate counting	Lifestyle, oral hypoglycemics, insulin	Monitoring, diet, insulin if needed

⚠️ Common Pitfalls & Confusions

1. Confusing autoimmune destruction (Type 1) with insulin resistance (Type 2).
2. Overlooking gestational diabetes as a transient condition with future risk.
3. Assuming all hyperglycemia symptoms are severe; some patients have mild or no symptoms.
4. Misidentifying diabetic ketoacidosis (DKA) as hyperosmolar hyperglycemic state (HHS).
5. Ignoring the role of insulin resistance in Type 2 diabetes pathophysiology.
6. Believing insulin therapy is only for Type 1; many Type 2 patients also require it.
7. Confusing microvascular (retinopathy, nephropathy) with macrovascular (cardiovascular) complications.
8. Underestimating the importance of early screening and regular monitoring.
9. Misinterpreting blood glucose thresholds for diagnosis.
10. Overlooking the significance of patient education in preventing complications.

✅ Exam Checklist

• Define the different types of diabetes and their key features.
• Explain the pathophysiology of Type 1 and Type 2 diabetes.
• Identify common signs and symptoms of hyperglycemia.
• Describe acute complications: DKA and HHS, including their signs and management.
• List chronic microvascular and macrovascular complications.
• State management goals: glycemic control, blood pressure, lipid levels.
• Outline nursing assessment components: blood glucose levels, symptoms, risk factors.
• Summarize patient education points: diet, exercise, medication adherence, foot and eye care.
• Describe insulin therapy types, administration, and monitoring.
• Explain the use of oral hypoglycemics and their mechanisms.
• Emphasize the importance of regular monitoring and follow-up.
• Recognize the significance of lifestyle modifications in management.